Latigo Biotherapeutics, Inc.
NASDAQLTGO short interest jumps 33.6% in one week to 339,209 shares, though cost to borrow eases to 3.6%. Availability remains ample at 135%, signaling easier shorting conditions despite the uptick.
Snapshot as of 20 Sept 2026
No long-form analysis yet for LTGO. Pulse alerts and the live data picture are available on ORTEX.
Open LTGO on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LTGO — free to start on ORTEX.
Sign up for free →Open LTGO on ORTEX